Financial reports
10-K
2023 FY
Annual report
28 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
ARS
2022 FY
Annual report to shareholders
24 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
16 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
30 Mar 22
Current reports
8-K
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
28 Mar 24
8-K
ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
14 Nov 23
8-K
ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update
14 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
10 Aug 23
8-K
Other Events
25 Jul 23
8-K
ENDRA Life Sciences Announces Adjournment of
6 Jul 23
8-K
ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update
15 May 23
8-K
ENDRA Life Sciences Announces Pricing of Upsized $4.5 Million Public Offering
2 May 23
8-K
Recent Financial Results
18 Apr 23
8-K
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
14 Mar 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
3 Apr 24
424B5
Prospectus supplement for primary offering
3 Apr 24
S-8
Registration of securities for employees
28 Mar 24
S-3/A
Shelf registration (amended)
28 Mar 24
S-3
Shelf registration
14 Feb 24
424B3
Prospectus supplement
29 Dec 23
424B5
Prospectus supplement for primary offering
14 Aug 23
424B5
Prospectus supplement for primary offering
28 Apr 23
S-1MEF
Registration of additional securities for an S-1
28 Apr 23
S-1/A
IPO registration (amended)
18 Apr 23
Proxies
DEFA14A
Additional proxy soliciting materials
25 Jul 23
DEFA14A
Additional proxy soliciting materials
6 Jul 23
DEFA14A
Additional proxy soliciting materials
24 May 23
DEF 14A
Definitive proxy
24 May 23
DEFA14A
Additional proxy soliciting materials
17 Oct 22
DEF 14A
Definitive proxy
17 Oct 22
PRE 14A
Preliminary proxy
27 Sep 22
DEFA14A
Additional proxy soliciting materials
21 Jun 22
DEFA14A
Additional proxy soliciting materials
17 May 22
DEFA14A
Additional proxy soliciting materials
2 May 22
Other
EFFECT
Notice of effectiveness
4 Apr 24
EFFECT
Notice of effectiveness
28 Apr 23
CORRESP
Correspondence with SEC
24 Apr 23
CORRESP
Correspondence with SEC
24 Apr 23
UPLOAD
Letter from SEC
7 Apr 23
EFFECT
Notice of effectiveness
4 May 21
CORRESP
Correspondence with SEC
29 Apr 21
UPLOAD
Letter from SEC
30 Mar 21
EFFECT
Notice of effectiveness
28 Jan 20
CORRESP
Correspondence with SEC
22 Jan 20
Ownership